Parikshit Padhi M.D., M.B.B.S.

Parikshit Padhi

Parikshit Padhi
M.D., M.B.B.S.

Clinical Assistant Professor

Department of Medicine

Jacobs School of Medicine & Biomedical Sciences

Specialty/Research Focus

Cancer Chemotherapy; Combination Chemotherapy; Hematology; Hemostasis / Thrombosis; Immune Checkpoint Inhibitors; Internal Medicine; Medical Oncology; Oncology

Contact Information
45 Spindrift Drive, Ste 100
Williamsville, New York 14221
Phone: 7164225422

Patient Care

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD

Professional Summary:

I am a medical hematologist and oncologist and provide comprehensive care towards patients with blood disorders and cancers. My interest lie in malignant hematology, breast cancers, melanomas and genitourinary cancers. I provide chemotherapy, immunotherapy and targeted therapy. My focus is ensuring that patients are provided with the best possible treatment and are treated with the utmost compassion. I believe in clinical research and I have been involved in multiple pharmaceutical and co-operative group trials.

I work in a multidisciplinary approach, as I believe that is the best way to treat cancers. This includes surgeons, radiation oncologists, radiologists, pathologists and other subspecialties. This ensures that all patients are provided with the best care.

I enjoy teaching students, residents and fellows. I mentor UB medical students, UB internal medicine residents, UB family medicine residents and hematology/oncology fellows. In my field along with teaching the fundamentals of blood disorders and management of cancers, I believe in teaching compassion and how to deal with difficult circumstances. My belief is if you can make a cancer patient smile and comfortable, then they are halfway there in their treatment journey and I instill that in future doctors and hematologists/oncologists.

Education and Training:

  • MD, Hematology and Oncology, Allegheny Health Network (2017)
  • MD, Internal Medicine, Allegheny Health Network (2014)
  • M.B.B.S., Kasturba Medical College, Manipal (2010)


  • Clinical Assistant Professor, Internal Medicine-Hematology and Oncology, Jacobs School of Medical and Biomedical Sciences, University at Buffalo (2022-present)
  • Adjunct Faculty, Internal Medicine-Hematology and Oncology, Burrell College of Osteopathic Medicine (2021–2022)
  • Co-chair of Internal Medicine, Internal Medicine, Memorial Medical Center, Las Cruces, NM (2021–2022)
  • Physician, Memorial Medical Cancer Center, Las Cruces, NM (2017–2022)
  • Member at Large, Memorial Medical Center, Las Cruces, NM (2020–2021)

Research Expertise:

  • Co-director of research at Great Lakes Cancer Center: I am a co-director for clinical trials at Great Lakes Cancer Center. We have a multitude of clinical trials in treatment and supportive care. My interests lie in breast cancer, lung cancers and hematological malignancies.
  • PRMC Member: Protocol Review Member for University of New Mexico

Journal Articles:


  • Pritam Tayshetye, Parikshit Padhi, Rohit Rao, Tatyana Yurievna Sklyar, Abhishek Chilkulwar, Rickey Miller, Amy Tang, Shifeng Mao. (2018) Bleomycin-induced pulmonary toxicity: A retrospective review of incidence and risk factors. Journal of Clinical Oncology, ASCO 2018. Chicago, Illinois (Jun)
  • Parikshit Padhi, MD, Abhishek Chilkulwar, MD, Cyrus Khan, MD, Monank Patel, PharmD, BCOP, John Lister, MD, Xiaoqin Tang, PhD Director of Biostatistics. (2016) Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubucin and Rituximab (da-EPOCH-R) Vs Rituxan, Cyclophosphamide, Doxorubucin, Vincristine and Prednisone (R-CHOP) As First Line Treatment for Diffuse Large B-Cell Lymphoma (DLBCL). Blood, ASH. (Dec), (627)

Evaluative Studies and Case Reports:

  • Parikshit Padhi M.D. Traci White PharmD Nesliha Cetin M.D. (2021) Successful Treatment of Nivolumab plus Ipilimumab--Mediated Pure Red-Cell Aplasia and Diabetes with Cyclosporine. Journal of Hematology Oncology Pharmacy (Oct), 11(5): 264-268.

Professional Memberships:

  • American Society of Clinical Oncology (2017–present)


  • "Reduced Intensity Conditioning (Fludarabine and Busulfan) for Allogeneic Hematopoietic Cell Transplantation in Patients with Severe Aplastic Anemia." ASBMT (2016)
  • "Reduced Intensity Fludarabine and Intravenous Busulfan (FB2) for Allogeneic Hematopoietic Cell Transplantion(allo-HCT)" ASBMT (2016)
  • "Adjuvant treatment for hormone positive (HR+) HER2 negative breast cancer" Grand Rounds Jan 2023

Service Activities:

  • I am the co-director of clinical research at Great Lakes Cancer Center. We are involved in multiple pharmaceutical clinical trials for our cancer patients.; Co-director for research at Great Lakes Cancer Center (2023–present)
  • I provide mentorship in the clinical practice of hematology and oncology for medical students who rotate through our cancer center.; Mentorship of students (2022–2023)

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

45 Spindrift Drive, Ste 100
Williamsville, New York 14221
Phone: 7164225422

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD